Instapath
Transform tissue samples into digital images in minutes, zero cutting, zero fixing.
Instapath develops fluorescence microscopy imaging platforms that digitize fresh pathology tissue samples in minutes at the point of procedure, with no cutting, fixing, or tissue loss. Their hardware lineup includes Nova (a Class I medical device for immediate tissue composition analysis), Luci (for large specimen imaging without destructive processing), and LuciNow (a remote on-demand slide scanning service). The technology preserves tissue integrity for downstream analytical testing while enabling rapid, high-quality previews without repeat procedures.
Patented fluorescence microscopy imaging platforms digitize fresh, fixed, or frozen tissue samples within minutes at the point of procedure without cutting or fixing the tissue.
Physicians, pathologists, and medical researchers performing tissue biopsies and specimen analysis
Background.
- Status
- launched
- Business model
- unknown
- Company
- Instapath Inc.
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.